Supernus Pharmaceuticals (SUPN) Other Operating Expenses (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Other Operating Expenses of $113.9 million for Q2 2026, up 202.61% year-over-year from $37.6 million in Q2 2025, and up 74.48% on a QoQ basis from $65.3 million in Q4 2025.
Supernus Pharmaceuticals (SUPN) Other Operating Expenses (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Other Operating Expenses for 16 years, with the latest figure at $113.9 million in Q2 2026.
- Other Operating Expenses for Q2 2026 came in at $113.9 million, up 202.61% year-over-year; the trailing twelve-month figure through Jun 2026 was $222.5 million (up 37.68% YoY), and the FY2025 annual result was $189.4 million, up 26.48% from the prior year.
- Other Operating Expenses climbed to $113.9 million in Q2 2026, from $65.3 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $113.9 million in Q2 2026 and troughed at $33.7 million in Q2 2024.
- A 5-year average of $47.5 million and a median of $41.8 million in 2022 frame the typical range for Other Operating Expenses.
- The widest annual swing landed in 2024, when Other Operating Expenses slipped 26.34%; it then soared 202.61% in 2026.
- A 5-year view of Other Operating Expenses shows it stood at $41.2 million in 2022, then soared by 47.11% to $60.7 million in 2023, then fell by 26.34% to $44.7 million in 2024, then surged by 46.07% to $65.3 million in 2025, then soared by 74.48% to $113.9 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $113.9 million in Q2 2026, $65.3 million in Q4 2025, and $43.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.76 Bn | 2.39 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113.92 Mn |
| Dec 31, 2025 | 65.29 Mn |
| Sep 30, 2025 | 43.29 Mn |
| Jun 30, 2025 | 37.65 Mn |
| Mar 31, 2025 | 43.21 Mn |
| Dec 31, 2024 | 44.70 Mn |
| Sep 30, 2024 | 36.06 Mn |
| Jun 30, 2024 | 33.67 Mn |
| Mar 31, 2024 | 35.35 Mn |
| Dec 31, 2023 | 60.68 Mn |
| Sep 30, 2023 | 40.39 Mn |
| Jun 30, 2023 | 41.99 Mn |
| Mar 31, 2023 | 41.78 Mn |
| Dec 31, 2022 | 41.25 Mn |
| Sep 30, 2022 | 47.01 Mn |
| Jun 30, 2022 | 41.84 Mn |
| Mar 31, 2022 | 39.24 Mn |
| Dec 31, 2021 | 30.14 Mn |
| Sep 30, 2021 | 24.17 Mn |
| Jun 30, 2021 | 22.23 Mn |